Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cytosine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step synthesis of Cytosine Nucleoside from cyanoacetaldehyde urea acetal. High yield, cost-effective route for antiviral API manufacturing.
Patent CN111377982B details a novel solid acid catalyzed glycosylation for decitabine intermediates, offering high beta-selectivity and simplified purification for pharmaceutical manufacturing.
Patent CN101391997B details a safer emtricitabine intermediate synthesis using triphosgene. Discover cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN100488977C details a high-yield cytidine synthesis route offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN111377986B details a novel purification method for decitabine intermediate II, removing critical impurities to enhance beta-configuration yield and supply reliability.
Novel amidation-first route for Capecitabine synthesis improves yield to 68% and purity. Cost-effective supply chain solution for oncology APIs.